Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades
about
HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinomaComparison of FOLFIRINOX Chemotherapy with Other Regimens in Patients with Biliary Tract Cancers: a Retrospective Study.Predictive Value of Early Skin Rash in Cetuximab-Based Therapy of Advanced Biliary Tract Cancer.Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma.
P2860
Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Identification of active chemo ...... trials in the past two decades
@ast
Identification of active chemo ...... trials in the past two decades
@en
type
label
Identification of active chemo ...... trials in the past two decades
@ast
Identification of active chemo ...... trials in the past two decades
@en
prefLabel
Identification of active chemo ...... trials in the past two decades
@ast
Identification of active chemo ...... trials in the past two decades
@en
P2093
P2860
P356
P1433
P1476
Identification of active chemo ...... trials in the past two decades
@en
P2093
Austin G Duffy
David J Liewehr
Metin Kurtoglu
Osama E Rahma
Oxana V Makarova-Rusher
Seth M Steinberg
Tim F Greten
P2860
P356
10.2217/HEP.14.36
P577
2015-01-01T00:00:00Z